Profile Validation 
Twitter 
Linked In 
Here at the HIMSS AI in Healthcare Forum, held in Brooklyn—long a gateway for immigration and innovation—the gathering has become more than just a platform to explore the intersection of “artificial intelligence” and human health. The gathering serves as a reminder of a deeper truth: science and human progress are fueled by global collaboration, and […]
The room was standing room only. At the HIMSS AI in Healthcare Forum, the energy was palpable, and the audience quiet and focused. This wasn’t a tech demo or a sales pitch. It was a gathering of health sector stewards—leaders seeking clarity amid the fog of anticipated disruption. Setting the tone for the two-day event […]
In a field increasingly shaped by digital transformation and clinical precision, it’s easy to overlook the human qualities that form the foundation of care. Yet those who lead with humility are often the ones guiding health forward. Among them is Rafael Grossmann, MD, MSHS, FACS—a trauma surgeon and digital health pioneer whose work spans the […]
“I know now why you cry. But it is something I can never do.”– The Terminator, T2: Judgment Day That moment, when the T-800, a machine built for destruction, understands human emotion, is among the most powerful in action cinema. It is the climax of Terminator 2: Judgment Day, but also a beginning: the start […]
I was in the media bullpen with the team when the future arrived. The launch of Roferon-A, alpha interferon marked a watershed moment in medicine: the first biotherapeutic to treat cancer, targeting the rare disease hairy-cell leukemia. I remember the packed press conference at The Pierre Hotel in New York City. Thought leaders like Dr. […]
This year’s gathering in Boston—a city long synonymous with health innovation—welcomed more than 20,000 attendees from across the globe. But what stood out most wasn’t just the buzz from traditional players like Cambridge and San Diego. It was the powerful presence of newer biotech ecosystems—places long underestimated yet now commanding attention: Austin, Italy, Northern Ireland, […]
When I first encountered Yasushi Yamamoto—musician, philosopher, investor, and Founder and CEO of Corundum—I was struck by how naturally he speaks of Renaissance ideals while steering a 21st-century venture fund. Yamamoto-san founded Corundum on the conviction that tomorrow’s most important medical solutions will be born only when deep science melds with art, philosophy, and finance […]
There’s a truth in health innovation: “Where data meets intent, change follows.” The latest Galen Growth report—FemTech 2.0: Doubling Down on Growth—is not just another data drop into the expanding ocean of digital health statistics. It’s a clarion call, a meticulously mapped road forward. It tells us that the investment conversation around FemTech is evolving […]
“Branding is a matter of building trust and committing to a level of quality and service. It is an emotional connection that transcends the actual product.” —Gil Bashe, “Global Marketing Strategies” and “Emotion: The New Brand Integrator,” Pharmaceutical Executive, 2000 Twenty-five years ago, in a series of articles for Pharmaceutical Executive that may have seemed […]
Data isn’t just an asset—it’s a trust marker. In life sciences, our credibility hinges on who contributes data and whether we are wise enough to listen. Patients aren’t just part of the story—they are the story. But where does that data come from, and who is contributing? It defines whether our innovations are truly inclusive, […]
